INIgor B. Nazarov

Igor B. Nazarov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Igor B. Nazarov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Aleksey Nikolaevich Tomilin

    Institute of Cytology, Russian Academy of Sciences, St. Petersburg 194064, Russia

    4 shared publications
  • Andrey V. Ilatovskiy

    Division of Molecular and Radiation Biophysics, B.P. Konstantinov Petersburg Nuclear Physics Institute, NRC "Kurchatov Institute", Orlova Roscha, Gatchina, 188300, Russia; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA

    1 shared publication
  • Colyn Crane-Robinson

    Biophysics Laboratories, St. Michael's Building, University of Portsmouth, Portsmouth, PO1 2DT, UK

    1 shared publication
  • Danil Zilov

    Tree of Life Programme, Wellcome Sanger Institute; Wellcome Genome Campus

    1 shared publication
  • E. I. Bakhmet

    Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia

    1 shared publication
  • Elena V. Skvortsova

    Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Ave. 4, 194064 St. Petersburg, Russia

    1 shared publication

Latest Publications

  • Open Access

    Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration

    by Igor B. Nazarov, Danil S. Zilov, Mikhail N. Gordeev, Evgenii V. Potapenko, Nataliya Yeremenko, Alexey N. Tomilin

    BOB1, a mammalian lymphocyte-specific transcriptional coactivator of the transcription factors OCT1 and OCT2 (OCT1/2), plays important roles in normal immune responses, autoimmunity, and hematologic malignancies. The issue of a DNA sequence preference change imposed by BOB1 was raised more than two decades ago but remains unresolved. In this paper, using the EMSA–SELEX–Seq approach, we have reassessed the intrinsic ability of BOB1 to modulate the specificity of DNA recognition by OCT1 and OCT2. Our results have reaffirmed previous conclusions regarding BOB1 selectivity towards the dimer configuration of OCT1/2. However, they suggest that the monomeric configuration of these factors, assembled on the classical octamer ATGCAAAT and related motifs, are the primary targets of BOB1. Our data further specify the DNA sequence preference imposed by BOB1 and predict the probability of ternary complex formation. These results provide an additional insight into the action of BOB1—an essential immune regulator and a promising molecular target for the treatment of autoimmune diseases and hematologic malignancies.


  • Open Access

    Dual Mode of Mitochondrial ROS Action during Reprogramming to Pluripotency

    by Elena V. Skvortsova, Igor B. Nazarov, Alexey N. Tomilin, Sergey A. Sinenko

    Essential changes in cell metabolism and redox signaling occur during the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). In this paper, using genetic and pharmacological approaches, we have investigated the role of electron transport chain (ETC) complex-I (CI) of mitochondria in the process of cell reprogramming to pluripotency. Knockdown of NADH-ubiquinone oxidoreductase core subunits S1 (Ndufs1) or subunit B10 (Ndufb10) of the CI or inhibition of this complex with rotenone during mouse embryonic fibroblast (MEF) reprogramming resulted in a significantly decreased number of induced pluripotent stem cells (iPSCs). We have found that mitochondria and ROS levels due course of the reprogramming tightly correlate with each other, both reaching peak by day 3 and significantly declining by day 10 of the process. The transient augmentation of mitochondrial reactive oxygen species (ROS) could be attenuated by antioxidant treatment, which ameliorated overall reprogramming. However, ROS scavenging after day 3 or during the entire course of reprogramming was suppressive for iPSC formation. The ROS scavenging within the CI-deficient iPSC-precursors did not improve, but further suppressed the reprogramming. Our data therefore point to distinct modes of mitochondrial ROS action during the early versus mid and late stages of reprogramming. The data further substantiate the paradigm that balanced levels of oxidative phosphorylation have to be maintained on the route to pluripotency.


  • KH-Domain Poly(C)-Binding Proteins as Versatile Regulators of Multiple Biological Processes

    by I. B. Nazarov, E. I. Bakhmet, A. N. Tomilin

    Five known members of the family of KH-domain poly(C)-binding proteins (Pcbp1-4, hnRNP-K) have an unusually broad spectrum of cellular functions that include regulation of gene transcription,...


  • Open Access

    AFM studies in diverse ionic environments of nucleosomes reconstituted on the 601 positioning sequence

    by Igor Nazarov, Iana Chekliarova, Georgy Rychkov, Andrey V. Ilatovskiy, Colyn Crane-Robinson, Alexey Tomilin